CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | CAPELLO JEFFREY D Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | CAPELLO JEFFREY D Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | CAPELLO JEFFREY D Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | Foster-Cheek Kaye I Director | Option exercise | +2,816 | 10,284 | ||
| 2026-06-18 | Foster-Cheek Kaye I Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Foster-Cheek Kaye I Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Foster-Cheek Kaye I Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | FOUSE JACQUALYN A Director | Option exercise | +2,816 | 154,156 | ||
| 2026-06-18 | FOUSE JACQUALYN A Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | FOUSE JACQUALYN A Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | FOUSE JACQUALYN A Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | Ho Maykin Director | Option exercise | +2,816 | 19,848 | ||
| 2026-06-18 | Ho Maykin Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Ho Maykin Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | Owen Adams Catherine Director | Option exercise | +2,816 | 10,865 | ||
| 2026-06-18 | Owen Adams Catherine Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Owen Adams Catherine Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Owen Adams Catherine Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-18 | Scadden David Director | Option exercise | +2,816 | 20,419 |
Page 2 of 48 · 941 trades